Genomic Landscape of a Three-Generation Pedigree Segregating Affective Disorder by Yang, Shuzhang et al.
Genomic Landscape of a Three-Generation Pedigree
Segregating Affective Disorder
Shuzhang Yang
1, Kai Wang
1, Brittany Gregory
1, Wade Berrettini
2, Li-San Wang
3,4, Hakon
Hakonarson
5,6*, Maja Bucan
1,5*
1Department of Genetics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, 2Department of Psychiatry, University of Pennsylvania,
Philadelphia, Pennsylvania, United States of America, 3Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of
America, 4Penn Center for Bioinformatics, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, 5Center for Applied Genomics, The Children’s
Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America, 6Division of Genetics, The Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania,
United States of America
Abstract
Bipolar disorder (BPD) is a common psychiatric illness with a complex mode of inheritance. Besides traditional linkage and
association studies, which require large sample sizes, analysis of common and rare chromosomal copy number variants
(CNVs) in extended families may provide novel insights into the genetic susceptibility of complex disorders. Using the
Illumina HumanHap550 BeadChip with over 550,000 SNP markers, we genotyped 46 individuals in a three-generation Old
Order Amish pedigree with 19 affected (16 BPD and three major depression) and 27 unaffected subjects. Using the
PennCNV algorithm, we identified 50 CNV regions that ranged in size from 12 to 885 kb and encompassed at least 10 single
nucleotide polymorphisms (SNPs). Of 19 well characterized CNV regions that were available for combined genotype-
expression analysis 11 (58%) were associated with expression changes of genes within, partially within or near these CNV
regions in fibroblasts or lymphoblastoid cell lines at a nominal P value ,0.05. To further investigate the mode of inheritance
of CNVs in the large pedigree, we analyzed a set of four CNVs, located at 6q27, 9q21.11, 12p13.31 and 15q11, all of which
were enriched in subjects with affective disorders. We additionally show that these variants affect the expression of
neuronal genes within or near the rearrangement. Our analysis suggests that family based studies of the combined effect of
common and rare CNVs at many loci may represent a useful approach in the genetic analysis of disease susceptibility of
mental disorders.
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Introduction
Recent large-scale studies showed a high degree of copy number
variation (CNV) in the human genome, suggesting that CNVs may
account for a significant proportion of human phenotypic
variation and disease susceptibility [1–6]. A significant fraction
of CNVs are likely to have functional consequences due to gene
dosage alteration, disruption of genes or gene-fusion, positional
effects, or the uncovering of deleterious alleles [7]. Genome-wide
searches for CNVs associating with schizophrenia identified a
greater burden of structural variation in individuals with
schizophrenia than in control subjects [8–11]. Moreover, associ-
ations with schizophrenia were found for large deletions at 1q21,
15q11.2 and 15q13.3 [11]. These studies support the idea that
many loci may contribute to the disease and that these genetic
factors may be common for several neuropsychiatric disorders.
The Old Order Amish is a genetically isolated population of
European descent located predominantly in Central Pennsylvania
[12], with large families segregating mental illness as well as several
metabolic and neurological disorders [13–16]. The advantages of
studying mental illness in the Old Order Amish, among others,
include: (1) The families are geographically and genetically
isolated, with a potentially reduced number of risk-factors for a
disease compared to a more heterogeneous population; (2) Large
sibships allow more direct comparisons between affected and
unaffected individuals in the same family; (3) Similar environmen-
tal influences, including lack of alcohol and drug use, may
minimize the potential confounding factors that contribute to
disease susceptibility [17]. The neuropsychiatric genetic studies in
Old Order Amish pedigrees included analysis of major affective
disorders (bipolar and unipolar forms). The original genetic
linkage studies in this pedigree reported positive findings on
chromosome 11 (11p15) [18]. However, a re-evaluation of
extended pedigrees and clinical updates did not support the
original finding [19–21]. Subsequent genome-wide linkage
analysis using 551 microsatellite markers revealed a complex
mode of inheritance with possible susceptibility loci on chromo-
somes 6, 13 and 15 [22] and a protective locus on 4p15 [23].
In this study, we used high density SNP genotype data to
identify structural variants in the core Old Order Amish pedigree
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repository family number 884) segregating mood or affective
disorders (BPD and major depression). We explored the potential
functional consequence of these genomic variants by examining
their frequency, size and gene content in affected and unaffected
family members, and their effects on gene expression in fibroblast
and/or lymphoblastoid cell-lines (LCLs). Our results indicate
presence of multiple micro-deletions and micro-duplications,
segregating in the large pedigree. Although the average number
and size of CNVs do not differ in affected and unaffected
individuals, we show that 58% of the tested CNVs (11 out of 19)
were associated with expression changes of genes within, partially
within or near these CNV regions in fibroblasts or LCLs. Several
CNVs frequently found in the affected family members alter
expression levels of genes involved in neurological functions. Our
results reveal previously unrecognized complex patterns of
inheritance for groups of CNVs.
Results
Genotyping and CNV identification
The three-generation Old Order Amish family 884 consists of
51 individuals, including 32 clinically unaffected family members
and 19 family members with affective disorders; among the 19
affected subjects, 16 have bipolar disorder type I (BPI), type II
(BPII) or not otherwise specified (BP-NOS), three with major
depression (MDD (Supplemental Table S1). Apart from general
medical histories abstracted for all patients with psychiatric
medical records (often multiple admissions) no additional general
medical screening for non-psychiatric conditions was done.
However, none of the important metabolic or neurological
disorders commonly found in the Amish were mentioned in their
psychiatric medical records and/or observed during decades of
contact with the subjects used in this study ( J. A. Egeland and A.
M. Hostetter, personal communication; see below).
DNA samples isolated from fibroblasts and/or lymphoblastoid
cell lines (when fibroblasts were not available) from these 51
individuals were genotyped with the Illumina HumanHap550
SNP genotyping array; 46 samples gave high quality data that
were subjected to CNV analysis. The five subjects with failed
genotyping include two healthy unaffected and three individuals
with a minor depressive disorder.
A non-parametric SNP-based linkage analysis performed using
the Merlin program [24] did not give significant or suggestive
linkage signals (maximum LOD score of 1.62 for chr14: 27.526–
29.525 Mb), further suggesting a complex mode of inheritance
with possible multiple low risk susceptibility loci, rather than a risk
attributable to a major gene(s). Based on this finding and recent
insights into the role of structural variants in etiology of
neuropsychiatric diseases, we attempted to utilize these high-
density SNP-genotype data to assess the extent of structural
variation in this family and to examine the effect of CNVs on the
expression of genes within and near breakpoints.
We used a high-resolution CNV detection algorithm,
PennCNV [25], to call CNVs from the signal intensity data, with
a threshold of 10 SNPs. This threshold was previously demon-
strated to result in a low false positive rate for high-quality samples
[25,26]. The PennCNV algorithm allowed us to detect four
abnormal copy number states other than the normal diploid state:
deletion by one or two copies and duplication by one or two copies
(Figure 1A). In total, we identified 388 CNVs that were classified
to 50 unique CNV regions (Table 1). Twenty-three of these CNV
regions map to genic and 27 CNVs to intergenic regions (Table 1).
The distribution of the CNVs present in four or more subjects are
illustrated in Supplemental Figure S1. The number of CNVs
ranges from four to 20 for each individual (mean=8.5; SD=2.9).
The size of these CNVs ranges from 12,447 bp to 885,204 bp
(mean=148,135 bp, median=80,890 bp). The average number
and size of CNVs that exist in affected individuals (including BPD
and major depression) are not significantly different from those of
CNVs exist in unaffected individuals (P=0.300 and 0.237
respectively, t-test), nor are they significantly different between
BPD and unaffected individuals (P=0.321 and 0.187 respectively,
t-test). The large pedigree size precludes the use of standard
family-based association test, we instead performed a permutation
procedure to adjust for the sibship relationships (Supplemental
Text S1). Although the permutation test revealed no significant
association between CNV genotype and disease status (Supple-
mental Table S2 and S3), we found four CNV regions (on 6q27,
9q21.11, 12p13.31 and 15q11.2.) at a nominally higher frequency
in individuals with affective disorders in comparison to healthy
family members.
By comparing the CNVs detected in the Amish pedigree with
those detected in a large control set of neurologically normal
individuals [27] and with those in the database of genomic variants
(http://projects.tcag.ca/variation), we identified 23 common
CNVs present in the Amish family and in 1000 control subjects
of European decent at a frequency of .1%. We found 27 CNVs
present in ,1% of subjects which were assigned as rare, 13 CNVs
were found only in Amish family 884, and were therefore
designated ‘‘Amish-specific’’ or ‘‘private’’ CNVs. (Table 1). The
distribution of 50 CNVs in family members is shown in the heat
map (Figure 1).
To experimentally validate the CNVs at a genomic level, we
randomly selected 6 CNV regions (at 4p12, 4q13.2, 6q14.1, 6q27,
12p13.31, and 15q14;Table 1) and examined their copynumber by
real-time quantitative PCR (QPCR) in fibroblasts or LCLs from 51
Amish family members. The QPCR experiment confirmed the
presence of these deletions or duplications in all subjects (Figure 2).
Our results indicate that the CNVs detected by computational
analysis of SNP genotyping data are highly reliable. Moreover, 19
CNVs were detected in family members across three generations
and they were inherited in a Mendelian fashion with identical
boundaries, suggesting that these variants are genetically stable.
CNVs affect gene expression
To investigate a potential pathogenic role of these CNVs, we
compared expression patterns of genes within and around these
chromosomal rearrangements (with a 2 Mb sweep) in individuals
with and without CNVs. Specifically, we examined the effects of
19 CNVs on gene expression using a combination of three
methods: a) thirteen CNVs with different copy numbers in four
individuals (GM05932, GM05934, GM05930 and GM05936)
were examined using microarray expression data of fibroblasts and
LCLs from these individuals; b) nine common CNVs (six of them
were also included in the analysis of the four subjects described
above) that also happened to exist in individuals from the Autism
Genetic Resource Exchange (AGRE) collection, were analyzed
using microarray expression data that are available in the public
domain [27,28]; c) four CNVs (including one examined in the
microarray analysis of four subjects described above, which serves
as a validation) were tested by QPCR in fibroblast samples from
48 individuals of Amish family 884 based on their higher
frequency in affected subjects. These genotype-expression analyses
revealed that, at a nominal P value ,0.05, 58% of the tested
CNVs (11 out of 19) were associated with expression changes of
genes within, partially within or near these CNV regions in
fibroblasts or LCLs (Supplemental Table S4 & S5).
CNVs in Affective Disorder
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to their enrichment in affected subjects ($70%), as well as their high
frequency in family 884 ($10 members) which will give reasonable
power to detect genotype-expression association by QPCR: a
common duplication on 6q27, a rare duplication on 9q21.11, and
a common deletion on 15q11.2 (Table 1). Although a common
duplication on 12p13.31 has a frequency of 56% in affected subjects,
permutation test controlling for family structure revealed a trend
toward significant association between CNV status and the disease
status at this loci, along with a CNV on 15q11.2. (Supplemental
Table S2). We found significant association between CNV status and
expression of genes within or near these structural variants.
Chr15: 21905523-22023095: This common deletion (117.6 kb)
was found in 10 subjects (seven affected including 6 BPD, and
Figure 1. Characteristic signal patterns of copy number states and the distribution of CNVs in family 884. (A–D) Visualization of signal
intensity for the CNV regions with 0 copy (A), 1 copy (B), 3 copies (C) and 4 copies (D) in the Illumina BeadStudio software. For each SNP, the Log R
Ratio (LRR) is a normalized measure of signal intensity for two alleles of a SNP, while the B Allele Frequency (BAF) is a normalized measure of the allelic
intensity ratio of the two alleles. Different copy number states have characteristic patterns of LRR and BAF. (E) Visualization of the CNVs by heatmap.
CNVs are ordered by chromosomes then by chromosomal positions by the NCBI Release 36 Human Genome. Clinical status for all subjects is
indicated by color; the respective hierarchical clustering was then computed for each group.
doi:10.1371/journal.pone.0004474.g001
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CNV region
1 #SNP
Length
(Kb) CN
2
Common
or rare
3
#subjects
(#affected)
4
Contained
Genes
Partially
contained
genes
Previously
reported linkage
Marker
5
chr1:53925291–53984359 14 59069 1 rare
3 1(0) GLIS1
chr1:66557267–66646247 29 88981 1 rare
3 1(0) PDE4B
chr1:84784450–84864145 16 79696 1 rare
3 1(0) CTBS SPATA1
chr1:101777242–101789688 10 12447 1 rare 4(0)
chr1:106411328–106634702 37 223375 3 rare 4(1)
chr1:159722810–159884140 15 161331 3 common 1(0) FCGR2A,FCGR2C,
FCGR3A,FCGR3B,
HSPA6
D1S2675
chr2:41083802–41099005 10 15204 1&0 common 23(5)
chr2:89714801–89877778 10 162978 1 common 7(1)
chr2:110186944–110339819 15 152876 1 common 8(2) MALL,NPHP1
chr3:5057955–5126637 24 68683 1 rare
3 4(0)
chr3:65166887–65187636 11 20,750 1 common 2(1)
chr3:165250428–165329628 10 79201 1 rare 4(1)
chr3:174501008–174623376 22 122369 1 rare
3 1(1) NLGN1 long
isoform
D3S1565
chr4:32994477–33055138 15 60662 1 rare 17(7)
chr4:47424121–47631300 23 207180 3 rare
3 20(6) NFXL1 CORIN
chr4:66521854–66632070 11 110217 1 rare
3 6(0)
chr4:161258794–161290832 20 32039 1 common 12(3)
chr4:162164752–162223074 14 58323 3 common 6(5)
chr5:97053242–97121798 15 68557 1 common 16(9)
chr6:67075448–67105019 13 29572 1 common 5(1)
chr6:79029920–79088461 24 58542 1&0 common 30(12)
chr6:124467336–124510591 12 43256 3 common 13(4) NKAIN not reported
chr6:168078929–168340091 120 261163 4 common 11(8) FRMD1,KIF25 MLLT4
chr7:34676579–34702727 12 26149 1 rare 2(0) NPSR1
chr7:61490330–62060344 17 570015 4 common 2(0)
chr7:75904125–76395148 23 491024 3 rare 3(0) DTX2,POMZP3,
UPK3B
ZP3
chr7:100715342–100914175 35 198834 3 rare 20(9) RABL5 EMID2 D7S518
chr7:141406463–141441259 14 33993 3 common 7(2) MGAM D7S2195
chr8:16256536–16692519 83 435984 1 rare 3(1)
chr8:43592905–43910848 26 317944 3 common 4(1)
chr9:71289871–71308782 10 18912 3 rare 15(11)
chr10:44523027–44679489 27 156463 3 rare 15(8)
chr10:47013328–47173619 35 160292 3 common 18(9)
chr11:50343409–51228612 19 885204 3 rare 3(0)
chr11:55127597–55204003 11 76407 1 common 19(9) OR4C11,OR4C6,
OR4P4,OR4S2
chr12:7884583–8017012 26 132430 3 common 16(9) SCL2A3 SLC2A14
chr12:34466271–34711193 11 244923 3 rare 1(0)
chr13:48903445–48961512 13 58068 1 rare
3 5(2) CAB39L,SETDB2 D11S153
chr13:61722125–62308067 107 585943 3 rare 22(7)
chr13:68611259–68643623 13 32365 3 rare
3 1(0)
chr14:47841003–47920779 13 79777 1 rare
3 4(0)
chr14:91996705–92036873 20 40169 1 rare
3 1(0) SLC24A4 GATA31B
chr15:21905523–22023095 15 117573 1 common 10(7)
chr15:32505886–32587887 11 82002 1 common 6(0)
chr16:34326402–34550666 11 224265 3 common 8(2)
CNVs in Affective Disorder
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QPCR in 48 fibroblasts from Amish family 884 revealed that this
CNV is associated with reduced expression of SNRPN (small
nuclear ribonucleoprotein polypeptide N) located 596 kb telomer-
ic of this CNV, and increased expression of NDN (necdin) located
422 kb centromeric of this CNV (P=0.039 and 0.003, respec-
tively; Figure 3B, C). The SNRPN-SNURF and NDN loci map to
the Prader-Willi syndrome region and are imprinted - expressed
from the paternal allele in brain tissues [29,30]. We found that this
deletion, when maternally inherited, is associated with an increase
of NDN expression (P=0.002, data not shown); however there
were no significant changes in NDN or SNRPN when the deletion
was paternally inherited (data not shown). Analysis of allele-
specific transcription will be required to address the effect of this
CNV on the expression and/or imprinting status of NDN and
SNRPN-SNURF loci.
Chr9: 71289871–71308782: This duplication (18.9 kb) within
the second intron of APBA1 (amyloid beta A4 precursor protein-
binding) was found in 15 individuals (four unaffected and eleven
affected, including 8 BPD subjects; Figure 3A, D). Although we did
not detect changes in expression of APBA1 in fibroblasts (Figure 3E),
this duplication was associated with an increase in expression of
KLF9 (Kruppel-like factor 9), located 910 kb telomeric of this CNV
(P=0.022, Figure 3E). KLF9 is a transcription factor that binds to
GC box elements of many promoters. This gene is expressed at a
high level in the hippocampus, amygdala, and cerebellum.
Figure 2. Validation of CNVs by QPCR in 51 individuals. The copy numbers detected by QPCR (bars) and PennCNV (circles) were plotted
against all individuals in family 884 (only the last four digits of the cell line IDs were shown). Black bars or circles indicate affected individuals
(including BPI, BPII, BP-NOS and MDD), white bars or circles indicate unaffected individuals. Note that the PennCNV calls were absent for subjects
5906, 5968, 5970, 6006, and 6024.
doi:10.1371/journal.pone.0004474.g002
CNV region
1 #SNP
Length
(Kb) CN
2
Common
or rare
3
#subjects
(#affected)
4
Contained
Genes
Partially
contained
genes
Previously
reported linkage
Marker
5
chr16:69251501–69354016 27 102516 1 rare
3 1(0) ABBA-1 C16orf77,VAC14
chr19:339413–371755 17 32343 1 common 1(1) SHC2
chr19:20422200–20520617 10 98418 1 common 11(4)
chr20:61056151–61070635 11 14485 1 rare 2(1) C20orf59 not reported
chr22:42613609–42627383 15 13775 1 rare
3 1(0) PNPLA5
1The chromosome coordinates are based on NCBI 36 human genome assembly.
2The CN represent the different aberrant copy numbers observed in this pedigree (normal copy number is 2).
3Marked are CNVs specific for Amish family 884.
4Number of subjects (members of family 884) that have that CNV. In brackets are number of affected individuals.
5Linkage markers that are within 2 Mbp of the CNVs, see [32] and references therein.
doi:10.1371/journal.pone.0004474.t001
Table 1. Cont.
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context-dependent fear conditioning [31].
Chr6:168078929–168340091: This common duplication
(207 kb) was detected in 11 individuals (three unaffected, eight
affected including 5 BPD) and encompasses KIF25 (Kinesin family
member 25, a member of the kinesin protein superfamily with a
role in organelle transport and cell division) and FRMD1 (FERM
domain containing 1, function unknown), as well as the 39 portion
of the MLLT4 (myeloid/lymphoid or mixed-lineage leukemia;
translocated to, 4) gene (Supplemental Figure S2A, B). All three
genes are expressed at low levels in fibroblasts and we were not
able to detect changes in expression in individuals with this
duplication (data not shown). We examined four genes (SFT2D1,
PRS6KA2, SMOC2, and THBS2) that are located within a 2 Mbp
region surrounding the boundaries of this CNV. The gene SMOC2
(Secreted modular calcium-binding protein 2), located 244 kb
telomeric of this CNV, has a higher expression in fibroblasts of
individuals with the duplication (Supplemental Figure S2C).
Chr12:7884583–8017012: This common duplication significant-
ly influenced gene expression in fibroblast cell lines. This
chromosomal region (132.4 kb), duplicated in 16 individuals
(seven unaffected, nine affected including 8 BPD), encompasses
the entire SLC2A3 gene and the first three exons of the paralogous
SLC2A14 gene (both genes encode neuronal glucose transporters)
(Figure 3A, F). This duplication was passed from the grandfather
(GM05962) to two affected and two unaffected children. Six out of
ten affected and five out of 20 unaffected grandchildren have this
rearrangement as well. Expression profiling in four Amish
individuals (two with this CNV and two without) revealed that
the SLC2A3 and SLC2A14 genes are expressed at a higher level in
Figure 3. CNVs frequently found in affected subjects were associated with changes in gene expression. (A) The distribution of three
CNVs in members of the Amish family 884. Ovals or bars below a subject indicate the presence of CNVs in that individual. Green indicates duplication
by one copy, red indicates deletion by one copy. (B) Diagram of the locus of a CNV region (indicated by the red bar) in chr15 showing surrounding
genes. Black arrows indicate genes examined in this study. (C) The CNV in chr15 was associated with altered expression of genes NDN (upper panel),
SNRPN (middle panel), and GABRB3 (lower panel). (D) Diagram of the locus of a CNV region (green bar) in chr9 located in the second intron of APBA1
gene. Black arrows indicate examined genes. (E) The CNV in chr9 does not affect the expression of APBA1 gene (upper panel), but it was associated
with altered expression of KLF9 (middle panel) and PRKACG (lower panel). (F) Diagram of the locus of a CNV region (green bar) in chr12 containing
gene SLC2A3 and partially containing SLC2A14. (G) The expression levels of SLC2A3 (top panels) and SLC2A14 (lower panels) in LCLs of four individuals
(GM05930, GM05932, GM05934, GM05936). Plotted are normalized data from microarray analysis for two or three probes. (H) The expression level of
SLC2A3 in 48 fibroblast samples from Amish family 884. CN, copy number. Data are mean6SE; P values were from t-test.
doi:10.1371/journal.pone.0004474.g003
CNVs in Affective Disorder
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region (Figure 3G and Supplemental Table S4). The CNV’s effect
on the SLC2A3 expression was further validated by QPCR in 48
fibroblasts from Amish family 884 (P=2.93E-7, t-test, Figure 3H).
The genotype-expression analysis supports previous reports that
a substantial portion of CNVs may affect gene expression. We
show that selected CNVs, frequently observed in affected members
of the 884 family, correlate with changes in the level of expression
of specific genes, located within or around the rearrangement.
However, despite their role in regulating expression of neuronal
genes and their enrichment in family members with affective
disorders, our work does not establish that any of the observed
CNV is the sole cause of bipolar disease in this pedigree, although
their potential role as risk factors can not be ruled out. Further
work is warrant to confirm or refine these findings in additional
family members and unrelated individuals.
Discussion
Structural variation including CNV constitutes a substantial
portion of total genetic variability and is important in under-
standing the biology of common disease. Using high-density arrays
we identified 50 deletions and duplications (with a threshold of
.10 SNPs) in the large Amish pedigree segregating BPD and
related mental disturbances. Although, the average number and
size of detected deletions and duplications in each individual did
not differ significantly between affected and unaffected family
members nor between this family and other ethnic groups of
European decent [27]. We show that 58% of the CNVs assayed in
our report are associated with changes in gene expression and can
be detected in one or both of two peripheral cell lines (fibroblasts
and LCL). Our analysis illustrates an advantage of using a
combination of cell lines to estimate pathogenic effects of
chromosomal rearrangements.
Extensive genetic studies in BPD have implicated a number of
susceptibility loci (reviewed in [32]); several collaborative efforts
have recently published whole-genome association studies with
BPD [33–36]. Although our analysis did not identify CNVs (with a
size $10 SNP threshold) in regions of these modest association
peaks or linkage peaks on chromosome 16, 13 and 15 that were
previously reported in this pedigree [22], several CNVs detected in
our study map in the vicinity of linkage peaks in other BPD studies
(Table 1). Functional studies of these variants will be needed to
evaluate their role in disease susceptibility. Several common CNVs
have been reported to be associated with complex diseases
(reviewed in [37]), however, these CNVs were identified by
candidate gene approaches instead of genome-wide and hypoth-
esis-free surveys [37]. Recent genome-wide studies in autism,
schizophrenia and Amyotrophic lateral sclerosis (ALS) suggest that
multiple rare deletions and duplications should be considered as
potential disease-predisposing factors [9,38,39]. Given the com-
plex nature of BPD and the substantial contribution of CNVs to
genetic heterogeneity, genome-wide survey of genomic aberrations
including common and low frequency (or rare) variants may
compensate traditional genetic analysis of BPD. A candidate gene-
driven analysis revealed a higher frequency of a CNV in BPD,
which was predicted to disrupt GSK3B gene [40]. The only
reported genome-wide copy number analysis in BPD has been
done using BAC array comparative genome hybridization (aCGH)
at 1.4 Mbp resolution; three CNVs containing genes involved in
glutamate signaling were identified in 5 or less out of 50 BPD
subjects [41]. However, the significant size-overestimation of
CNVs identified by BAC aCGH [42] indicate that a more
systematic approach is needed to detect CNVs in BPD. Although
small in scale and limited to one large pedigree, our analysis of
CNVs in the Old Order Amish pedigree represents the first high
resolution genome-wide survey of CNVs in BPD.
A unique aspect of our study is the family-based multigener-
ational analysis, which permits examination of the inheritance
patterns of the CNVs and facilitates validation of computationally
predicted CNVs. More importantly, our study provides a proof of
principle for a family-based investigation of a summation or
combination of a series of common and rare CNVs involving
different genes and genomic regions that could confer low or
moderate risk for a disease. For example, a larger pedigree would
afford more power to identify individuals sharing not only the
same rare structural variant, but in some cases, the same
combination of variants involving different genes or intergenic
regions. Furthermore, as implicated by our analysis of CNV’s
effect on SNRPN and NDN expression, epigenetic modifications
and an imbalance in the level of expression between two
homologous chromosomes may lead to marked differences in the
effect of a deletion or duplication. Measurements of an allelic
imbalance in multiple family members carrying the same rare
structural variant, on either the maternal or paternal chromosome,
provide a unique advantage of family-based genotype-expression-
phenotype analysis.
Our study includes extensive experimental validation of
detected CNVs, as well as analysis of the effect of a subset of
randomly selected CNVs on gene expression. Although a recent
study of gene expression in LCLs of four ethnic groups (each
consisting of 45–60 individuals) revealed a substantial effect of
CNVs on gene expression and predicted that CNVs account for at
least 17.7% of genetic variation in gene expression [7], we evaluate
effects of specific CNVs, some of them frequently found in affected
family members. Previous analyses of CNVs in human diseases
rarely investigated the potential contribution of the CNVs through
regulating expression of surrounding genes, which account more
than half of the CNV regulated genes in LCLs [7]. Our genotype-
expression analysis of 19 CNVs in two cell lines (LCLs and
fibroblasts) showed that the majority of changes were detected in
genes outside the deleted or duplicated regions (for example,
SNRPN, NDN and KLF9). These findings illustrate that for the
evaluation of the functional role of CNVs it will be critical to have
deeper insight into regulatory elements in the intergenic and
intronic regions affected by these rearrangements. Although
caution is required to conclude any causal role of the CNV-
induced gene expression change in the etiology of BPD, they may
serve as candidate potential risk factors warrant further study.
The limitation of our study is the relatively small subject size,
which resulted in no significant association between CNVs and
BPD. Future studies should include the entire Old Order Amish
family 884 (over 400 individuals), along with the fourth generation
which is already enroled in this longitudinal and prodromal study
[43]. Furthermore, analysis of low frequency variants in additional
large families and different ethnic groups may increase the pool of
variants. Another limitation of our study is the use of cell lines,
rather than brain tissues, for expression analysis. Although we
found that 58–71% of 2563 neuronal genes (3077 unique
transcripts represented by 3185 probes on the expression array)
are expressed in two peripheral cell lines (LCLs and fibroblasts
respectively, Supplemental Figure S3), the effect of CNVs on gene
expression may differ in these cell lines in comparison to brain
tissues. It is therefore critical to extend the genotype-expression
analysis to neuronal tissues, such as sections of postmortem brain
regions or olfactory epidermal biopsies, to investigate the
functional role of these genetic traits in the pathogenesis of
affective disorders.
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884 segregating affective illness, particularly BPD. Functional
annotation of the genes affected by common, rare and ‘‘Amish-
specific’’ or ‘‘private’’ CNVs will provide an important avenue
towards establishing molecular links to complex clinical pheno-
types, such as affective disorders in this family. Our results support
the concept that BPD, even in a genetically isolated family (Amish
family 884), is a complex disorder and a combination of multiple
genetic lesions likely contribute to its pathogenesis. Our data also
suggest that studying the functional consequence of CNVs by
examining their effects on gene expression may shed new lights to
dissecting the etiology of affective disorders including BPD.
Materials and Methods
Cell culture and isolation of DNA and RNA
Forty-eight fibroblast cell lines and seven lymphoblastoid cell
lines (LCLs) (Supplemental Table S1) from the Old Order Amish
family 884 were purchased from Coriell cell repositories (Coriell
Institute for Medical Research, Camden, NJ). The cells were
cultured according to the provider’s recommendation as previ-
ously described [44]. The genomic DNA was isolated using a
Genomic DNA Purification Kit (Gentra Systems, Minneapolis,
Minnesota). Total RNA was isolated by Trizol reagent as
described previously [45], from which the cDNA was generated
using the high-capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City, CA).
Genotyping and identification of copy number variant
(CNV)
The genomic DNA from fibroblasts or LCLs was used to obtain
genotypes by the Illumina HumanHap550 version 3 high-density
arrays with 561,446 SNP markers. The genotyping experiments
were performed at the Center for Applied Genomics, Children’s
Hospital of Philadelphia as previously described [46]. The raw
genotyping signal data were processed by the Illumina BeadStudio
software and converted to signal intensity values, represented as
Log R Ratio (LRR) and B Allele Frequency (BAF). Due to the
presence of ‘‘genomic wave patterns’’ in some of the genotyped
samples, we applied a data pre-processing protocol [47] to increase
the signal-to-noise ratio of the LRR values for all samples. We
have confirmed in three individuals that the SNP genotypes using
DNA from fibroblasts were nearly identical to those obtained using
DNA from LCLs of the same individual (concordance rate
.99.99%), thus justifying the combined analysis of genotyping
data from these two types of cells.
A previously described high-resolution CNV detection algo-
rithm, the PennCNV algorithm [25], was used to infer CNVs from
the signal intensity data. This algorithm incorporates multiple
sources of information, including total signal intensity and allelic
intensity ratio at each SNP marker, the distance between
neighboring SNPs, the allele frequency of SNPs, as well as family
information when available. By taking advantage of the pedigree
structure, we split the large family into quartets and trios and
applied the posterior validation procedure in PennCNV algorithm
for more accurate CNV detection and boundary mapping. We set
a threshold at 10 SNPs to avoid false positive calls. This threshold
was previously shown to result in a false positive rate lower than
1% for high-quality samples [25,26].
To define common and rare CNVs we mapped these CNVs to
the UCSC genome browser for comparison with those previously
identified in other publications [9,27], or with those included in
the database of genomic variants (http://projects.tcag.ca/varia-
tion). The common and rare CNVs were defined as those that
occurred at a frequency of .1% or ,1% in general populations.
The CNVs which were not detected in control subjects or in the
database of genomic variants were considered ‘‘Amish-specific’’ or
‘‘private’’.
To identify CNVs that are prevalent in affected and/or
unaffected subjects, we performed permutation test for each
CNV. (see Supporting Text S1)
Microarray and CNV-expression association
Five mg of total RNA from fibroblasts and LCLs of four
individuals (GM05931, GM05933, GM05935, and GM05937)
were subjected to microarray experiments using the HG U133A
2.0 Array (Affymetrix, Santa Clara, CA). These four individuals
are siblings within a large sibship; two of them have BPD (BPI).
Data processing was carried out as described previously [45].
Briefly, Affymetrix Microarray Suite 5.0 was used to quantitate
expression levels and assign Calls (Flags of present, marginal, and
absent) for each probe set. The CEL files were used to generate
normalized expression data that were corrected by the GCRMA
algorithm. The normalized expression data for probes located
within a 2 Mb region surrounding each boundary SNP of a CNV
were subjected to association study. A gene was considered to be
regulated by a CNV if its expression levels in fibroblasts or LCLs
correlated (or inversely correlated) with the copy numbers of
respective CNVs (regression P,0.05) and there was .1.5 fold
change in their expression levels among the four individuals. The
microarray expression data have been deposited to GEO
(GSE11767).
In addition, we retrieved from GEO the expression profiling
data for 30 LCLs (GSE7329) which were included in a study for
autism [28]. We have also genotyped these 30 LCLs by the same
Illumina HumanHap550 platform with the same genotyping
protocol for the Amish families [27]. From these 30 LCLs, we
identified nine CNVs using the PennCNV algorithm that also exist
in Amish family 884 and were present in at least three of these 30
individuals. Regression analysis was performed on expression data
for genes located within a 2 Mb region flanking the boundaries of
these eight CNVs, and the genes yielding a P,0.05 were
considered to be potentially associated with the corresponding
CNV.
CNV validation and gene expression quantification
We employed real-time quantitative PCR (QPCR) using
relative quantification method with SYBR Green Dye to validate
CNVs and to quantify gene expression. Six CNVs were randomly
selected and PrimerExpress2.0 software was used to design primer
pairs that target the CNV regions. The endogenous control for
CNV validation was designed to target a region in chromosome 12
within the DEC2 gene that is free of any known structural variants
in both Amish family 884 and in the general population. The
primer pairs for gene expression were designed to target exon-
exon junctions if the target gene contains multiple exons. The
endogenous control for gene expression analysis was b-actin. The
sequences for these primers are listed in Supplemental Table S6.
A different batch of genomic DNA was isolated from fibroblasts
or LCLs of all the 51 individuals in Amish family 884 and
subjected to CNV validation. For gene expression quantification,
cDNA samples prepared from 48 fibroblast cell lines were
examined. The real-time PCR was done on the ABI Prism
7900HT system (Applied Biosystems, Foster City, CA) and the
data were analyzed as described previously [44]. The relative
quantity of the genomic copy numbers or the gene expression
levels was normalized to GM05889, an individual that has none of
CNVs in Affective Disorder
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CNV regions and a gene expression level of 1 for all transcripts.
Supporting Information
Text S1 Permutation Tests for Association Between CNV status
and Phenotype
Found at: doi:10.1371/journal.pone.0004474.s001 (0.09 MB
DOC)
Table S1 Cell lines and Disorder versus Normal groups for the
phenotype-genotype association analysis
Found at: doi:10.1371/journal.pone.0004474.s002 (0.16 MB
DOC)
Table S2 P-values of odds ratios for individual CNV regions
Found at: doi:10.1371/journal.pone.0004474.s003 (0.25 MB
DOC)
Table S3 P-values of adjusted ratios
Found at: doi:10.1371/journal.pone.0004474.s004 (0.08 MB
DOC)
Table S4 Genes with expression levels associated with CNVs
(indicated by chromosomal coordinates in bold) in fibroblasts and
LCLs of 4 Amish individuals
Found at: doi:10.1371/journal.pone.0004474.s005 (0.08 MB
DOC)
Table S5 Genes with expression levels associated with CNVs
(indicated by chromosomal coordinates in bold) in LCLs of 30
AGRE individuals (Nishimura, Y., et al. 2007 Hum Mol Genet 16,
1682–98)
Found at: doi:10.1371/journal.pone.0004474.s006 (0.04 MB
DOC)
Table S6 Primer sequences corresponding to genomic or cDNA
regions for CNV validation and gene expression by QPCR
Found at: doi:10.1371/journal.pone.0004474.s007 (0.05 MB
DOC)
Figure S1 Distribution of 32 CNVs present in four or more
individuals in family 884. Colored ovals indicate the presence of
CNV in that individual. The number of copies are indicated by
different colors.
Found at: doi:10.1371/journal.pone.0004474.s008 (5.18 MB EPS)
Figure S2 A duplication in chromosome 6 correlates with
changes in SMOC2 gene expression. (A) The distribution of this
duplication (two copies) in Family 884. Marked are subjects with
this CNV. (B) Diagram of the locus of this CNV region in chr6.
Genes examined in this study are indicated by black arrows. (C)
This CNV is associated with increased expression of SMOC2, but
not MLLT4, in fibroblasts. The expression of genes KIF25 and
FRMD1 were not detectable.
Found at: doi:10.1371/journal.pone.0004474.s009 (1.02 MB EPS)
Figure S3 Fibroblasts and LCLs express a large number of
neuronal genes. (A) Venn diagram showing the number of genes
expressed in fibroblasts and LCLs (genes present or marginal in all
four individuals by expression profiling using the Affymetrix
HG_U133A_2 arrays), and the overlap between neuronal genes
(genes expressed .4 fold higher in any of the 23 neuronal tissues
than the 52 non-fetal non-neuronal tissues in GNF data [Su AI,
Cooke MP, Ching KA, Hakak Y, Walker JR, et al. (2002) Large-
scale analysis of the human and mouse transcriptomes. Proc Natl
Acad Sci U S A 99: 4465–4470. ]). Expression of 71.0% neuronal
genes can be detected in fibroblasts, 58.0% in LCLs, and 24.6%
neuronal genes were not detectable in any of these cell lines (B) The
hierarchical clustering of neuronal gene expression in fibroblasts
(left) and LCLs (right) in four individuals using GeneSpring 7.2
software. The color bar indicates normalized expression level. More
neuronal genes are expressed at high levels in fibroblasts than in
LCLs, indicating that fibroblasts maybe better suited than LCLs for
studying neurological disease. However, most of the neuronal genes
tend to be highly expressed in either fibroblasts or LCLs, but not
both, suggesting that fibroblasts and LCLs can complement each
other in studying neuronal gene expression.
Found at: doi:10.1371/journal.pone.0004474.s010 (1.32 MB EPS)
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